Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Director/PDMR Shareholding

29 Oct 2021 17:26

RNS Number : 7982Q
Creightons PLC
29 October 2021
 

 

29 October 2021

 

 

 

Creightons PLC ("Creightons" or the "Company")

 

Director/PDMR Option Exercise and Total Voting Rights

 

Creightons plc (LSE: CRL), manufacturers of personal care, beauty, and fragrance products announces that Mr William Glencross, Director, has exercised options issued under the Company's share option scheme (the "Option Scheme") over 18,500 ordinary 1p shares in the Company at 26.80 pence per share, and that Mr Glencross's beneficial holding in the Company after this transaction will be 86,000 ordinary 1p shares (0.13% of the expanded share capital detailed below).

 

The Company also announces that Mr Nicholas O'Shea, Director, has exercised options issued under the Company's share option scheme (the "Option Scheme") over 15,000 ordinary 1p shares in the Company at 26.80 pence per share, and that Mr O'Shea's beneficial holding in the Company after this transaction will be 115,000 ordinary 1p shares (0.17% of the expanded share capital detailed below).

As a result of these issues, the total number of ordinary 1p shares in issue now stands at 68,394,894 and the total number of voting rights in the Company is therefore 68,394,894.

The above figure of 68,394,894 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Following these share issues the Company has the ability to issue a further 6,864,849 ordinary 1p shares under its block listing facility.

Market Abuse Regulation

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").

 

Contacts

 

Nicholas O'Shea, Creightons plc 01733 281000

Roland Cornish /Felicity Geidt, Beaumont Cornish Limited 0207 628 3396

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail in respect of the Directors subscribing for Director Shares as described above.

 

William Glencross - exercise of options

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

William Glencross

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creightons plc

b)

LEI

213800WROWAJUBGSAJ57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1pence each in Creightons plc

 

ISIN GB0002341666

 

Nature of the transaction

Option Exercise

 

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

£0.268

18,500

 

d)

Aggregated information

n/a

e)

Date of the transaction

29 October 2021

f)

Place of the transaction

London Stock Exchange, (GLR)

 

 

Nicholas O'Shea - exercise of options

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Nicholas O'Shea

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creightons plc

b)

LEI

213800WROWAJUBGSAJ57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1pence each in Creightons plc

 

ISIN GB0002341666

 

Nature of the transaction

Option Exercise

 

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

£0.268

15,000

 

d)

Aggregated information

n/a

e)

Date of the transaction

29 October 2021

f)

Place of the transaction

London Stock Exchange, (GLR)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMLBFTMTTTBIB
Date   Source Headline
29th Oct 20213:53 pmRNSDirector/PDMR Shareholding
28th Oct 202111:24 amRNSDirector/PDMR Shareholding
22nd Oct 20217:00 amRNSDirector/PDMR Shareholding, Total Voting Rights
21st Oct 20217:00 amRNSDirector/PDMR Shareholding
5th Oct 20213:57 pmRNSDirector/PDMR Shareholding
5th Oct 20213:51 pmRNSDirector/PDMR Shareholding
4th Oct 20219:12 amRNSTotal Voting Rights
30th Sep 20216:29 pmRNSListing Application
27th Sep 20217:00 amRNSAcquisition of Brodie and Stone
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20217:00 amRNSBlock listing Interim Review
3rd Sep 20219:30 amRNSTotal Voting Rights
26th Aug 202111:19 amRNSFinal Dividend Declaration
25th Aug 20211:34 pmRNSResults of AGM, Final Dividend Declaration
4th Aug 20211:47 pmRNSEmma Hardie Ltd - Q&A video available
29th Jul 20217:00 amRNSAcquisition of Emma Hardie Limited and TVR
21st Jul 20212:05 pmRNSSecond Price Monitoring Extn
21st Jul 20212:00 pmRNSPrice Monitoring Extension
21st Jul 202111:05 amRNSSecond Price Monitoring Extn
21st Jul 202111:00 amRNSPrice Monitoring Extension
21st Jul 20219:05 amRNSSecond Price Monitoring Extn
21st Jul 20219:00 amRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSPreliminary Results - for year ended 31 March 2021
20th Jul 20214:17 pmRNSNotice of Results and Presentation
6th Jul 20213:24 pmRNSUpdate on Notice of Final Results
24th Jun 20217:00 amRNSPresentation on Final Results
26th Mar 202111:35 amRNSChange of Director's Role
18th Mar 20217:00 amRNSBlock Listing Six Monthly Review
16th Mar 202111:42 amRNSShare Option Grant
9th Mar 20219:52 amRNSDirector/PDMR Shareholding
25th Feb 20212:54 pmRNSDirector/PDMR Shareholding
24th Feb 20215:28 pmRNSFurther Statement regarding Innovaderma
24th Feb 20214:46 pmRNSForm 8.3 - Creightons PLC
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 20218:43 amRNSForm 8 (OPD) Creightons plc
5th Feb 20215:15 pmRNSForm 8.3 - Creightons plc
4th Feb 20216:28 pmRNSRule 2.9 Announcement
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
3rd Feb 202112:14 pmGNWForm 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 20217:00 amRNSStatement regarding Innovaderma plc
9th Dec 20207:00 amRNSHalf-year Report
24th Nov 20209:28 amRNSChange of Auditor
24th Nov 20209:19 amRNSInterim Results Presentation
30th Sep 20205:39 pmRNSResult of AGM
18th Sep 202011:37 amRNSBlock listing Interim Review
16th Sep 202011:49 amRNSHolding(s) in Company
8th Sep 20205:47 pmRNSDirector/PDMR Shareholding
8th Sep 20204:50 pmRNSReport and Accounts, AGM and Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.